Literature DB >> 1955127

Enhanced perception of physiological intestinal motility in the irritable bowel syndrome.

J E Kellow1, C M Eckersley, M P Jones.   

Abstract

An increased awareness of intestinal distention or contraction is implicated in the pathogenesis of the irritable bowel syndrome. This study aimed to test this hypothesis in 20 patients with the irritable bowel syndrome and 10 controls by relating the reporting of abdominal sensations to the occurrence of the duodenal phase 3 activity front of the migrating motor complex. During prolonged recordings of interdigestive small bowel motility, subjects were asked to report any episodes of abdominal sensation they experienced. Diurnally, the rate of occurrence of abdominal sensation was significantly greater in patients with the irritable bowel syndrome than in controls (P less than 0.001); such episodes were coincident with a duodenal activity front in 9 patients with the irritable bowel syndrome and in 1 control (P less than .05). Moreover, the rate of occurrence of episodes of sensation was greater (P less than 0.01) during diurnal phase 3 activity than during diurnal phase 2 activity. When episodes were coincident with duodenal phase 3 activity, these activity fronts were of significantly greater amplitude (irritable bowel syndrome: median, 23 mm Hg) than "noncoincident" activity fronts (median, 17 mm Hg; P less than 0.05) in both patients and controls. These data strongly suggest that certain physiological small bowel motor events, if of sufficient contraction amplitude, are able to be perceived by a greater proportion of irritable bowel syndrome patients and with greater frequency than by healthy subjects. The authors conclude that the threshold for perception of intestinal contraction is lower than normal in at least some patients with the irritable bowel syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 1955127     DOI: 10.1016/0016-5085(91)90400-f

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

Review 1.  Spinal and supraspinal modulation of visceral sensation.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

3.  Bloating and intestinal gas.

Authors:  Michael P Jones
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

4.  Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Bruce D Naliboff; Steve M Berman; Brandall Suyenobu; Eduardo P Vianna; Kirsten Tillisch; Emeran A Mayer
Journal:  Neuroimage       Date:  2009-06-06       Impact factor: 6.556

Review 5.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Cerebral Activity in the Perception of Visceral Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

7.  Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity.

Authors:  K C Trimble; R Farouk; A Pryde; S Douglas; R C Heading
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

9.  Effect of the quaternary ammonium compound trospium chloride on 24 hour jejunal motility in healthy subjects.

Authors:  T Schmidt; R Widmer; A Pfeiffer; H Kaess
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.